Literature DB >> 32239394

Musculin Deficiency Aggravates Colonic Injury and Inflammation in Mice with Inflammatory Bowel Disease.

Jing Yu1, Yijia Liu1,2, Wei Zhang3, Xue Yang1, Wanqi Tang1, Huaping Liang1, Suiyan Li2, Wenda Gao4, Jun Yan5.   

Abstract

Intestinal inflammatory reactions and resulting tissue injuries are two major aspects of inflammatory bowel disease (IBD). The regulatory factors involved in the pathogenesis of IBD remain unclear. Recent studies showed that musculin (MSC) as a transcription suppressor participates in the regulation of certain immune functions. The purpose of this study was to determine the impact of MSC deficiency on colonic injury and inflammatory reaction under IBD, where wild-type (WT, +/+) and MSC-knockout (MSCKO, MSC-/-) mice were induced for disease by dextran sulfate sodium (DSS) in drinking water. Immunohistochemistry hematoxylin-eosin (H&E) staining, enzyme-linked immunosorbent assay (ELISA), and quantitative real-time polymerase chain reaction (qRT-PCR) were used to analyze the matching samples from groups of different genotypes. The colonic epithelial injury in the MSC-/- IBD group was much severer than that in the +/+ IBD group, concurrent with higher IL-22 levels from the supernatant of ex vivo cultured colon tissues in the MSC-/- IBD group than those in the +/+ IBD group. The mRNA levels of IL-22 in mesenteric lymph nodes (MLN) also manifested similar tendency. MSC deficiency may enhance the inflammatory reactions in the gut via excessive secretion of IL-22, leading to aggravated colonic epithelial injury under IBD.

Entities:  

Keywords:  colonic injury; inflammation; inflammatory bowel disease (IBD); musculin (MSC)

Mesh:

Substances:

Year:  2020        PMID: 32239394     DOI: 10.1007/s10753-020-01223-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.657


  22 in total

1.  Control of facial muscle development by MyoR and capsulin.

Authors:  Jian-Rong Lu; Rhonda Bassel-Duby; April Hawkins; Priscilla Chang; Renee Valdez; Hai Wu; Lin Gan; John M Shelton; James A Richardson; Eric N Olson
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

2.  Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity.

Authors:  Veronica Santarlasci; Alessio Mazzoni; Manuela Capone; Maria Caterina Rossi; Laura Maggi; Gianni Montaini; Beatrice Rossettini; Rolando Cimaz; Matteo Ramazzotti; Giusi Barra; Raffaele De Palma; Enrico Maggi; Francesco Liotta; Lorenzo Cosmi; Sergio Romagnani; Francesco Annunziato
Journal:  Eur J Immunol       Date:  2017-07-06       Impact factor: 5.532

3.  Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.

Authors:  Yuichiro Shindo; Anja G Fuchs; Christopher G Davis; Tim Eitas; Jacqueline Unsinger; Carey-Ann D Burnham; Jonathan M Green; Michel Morre; Grant V Bochicchio; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

4.  Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.

Authors:  M E Massari; R R Rivera; J R Voland; M W Quong; T M Breit; J J van Dongen; O de Smit; C Murre
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

5.  MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD.

Authors:  J Lu; R Webb; J A Richardson; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 6.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 7.  Inflammatory bowel disease.

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  The transcription factor musculin promotes the unidirectional development of peripheral Treg cells by suppressing the TH2 transcriptional program.

Authors:  Chuan Wu; Zuojia Chen; Valerie Dardalhon; Sheng Xiao; Theresa Thalhamer; Mengyang Liao; Asaf Madi; Rafael F Franca; Timothy Han; Mohammed Oukka; Vijay Kuchroo
Journal:  Nat Immunol       Date:  2017-01-23       Impact factor: 25.606

9.  MyoR is expressed in nonmyogenic cells and can inhibit their differentiation.

Authors:  Liming Yu; Jerome Mikloucich; Niquiche Sangster; Ana Perez; Paulette J McCormick
Journal:  Exp Cell Res       Date:  2003-09-10       Impact factor: 3.905

10.  Myor/ABF-1 mRNA [corrected] Expression Marks Follicular Helper T Cells but Is Dispensable for Tfh Cell Differentiation and Function In Vivo.

Authors:  Delphine Debuisson; Nathalie Mari; Sébastien Denanglaire; Oberdan Leo; Fabienne Andris
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

View more
  1 in total

1.  The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells.

Authors:  Jun Yan; Jing Yu; Ke Liu; Yijia Liu; Changchuin Mao; Wenda Gao
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.